2-Year Treasury Yield Falls to 3.562% This Week — Data Talk
The 2-year yield declined 0.011 percentage point to 3.562% this week. The price is 99 28/32.
--Yield is down for four consecutive weeks
--Yield is down 0.364 percentage point over the last four weeks
--Largest four-week yield decline since the week ending Sept. 13, 2024
--Longest streak of falling yields since the week ending Dec. 11, 2020, when the yield fell for four straight weeks
--Yield is down five of the past six weeks
--Today it is down 0.058 percentage point and the price rose 4/32 price points
--Largest one-day yield decline since Friday, Sept. 13, 2024
--Snaps a two-trading-day streak of rising yields
--Today's yield is the fourth lowest this year
--Yield is off 1.656 percentage points from its 52-week high of 5.218% hit Wednesday, Oct. 18, 2023
--Yield is up 0.013 percentage point from its 52-week low of 3.549% hit Tuesday, Sept. 24, 2024
--Yield is down 1.484 percentage points from 52 weeks ago
--Yield is off 1.481 percentage points from its 2024 closing high of 5.043
% hit Tuesday, April 30, 2024
--Month-to-date the yield is down 0.364 percentage point
--Year-to-date the yield is down 0.686 percentage point
Data based on 3 p.m. ET values
Source: Tradeweb FTSE U.S. Treasury Closing Prices
(END) Dow Jones Newswires
September 27, 2024 15:48 ET (19:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks